Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study

{ 'indexed': {'date-parts': [[2024, 6, 12]], 'date-time': '2024-06-12T05:17:46Z', 'timestamp': 1718169466802}, 'reference-count': 57, 'publisher': 'Springer Science and Business Media LLC', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2023, 6, 24]], 'date-time': '2023-06-24T00:00:00Z', 'timestamp': 1687564800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}, { 'start': { 'date-parts': [[2023, 6, 24]], 'date-time': '2023-06-24T00:00:00Z', 'timestamp': 1687564800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}], 'funder': [ { 'DOI': '10.13039/501100013041', 'name': 'Vice-Chancellor for Research, Shiraz University of Medical Sciences', 'doi-asserted-by': 'publisher', 'award': ['IR.SUMS.MED.REC.1399.550']}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1007/s40618-023-02141-0', 'type': 'journal-article', 'created': {'date-parts': [[2023, 6, 24]], 'date-time': '2023-06-24T11:59:54Z', 'timestamp': 1687607994000}, 'page': '235-243', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 2, 'title': 'Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with ' 'COVID-19: a prospective cohort study', 'prefix': '10.1007', 'volume': '47', 'author': [ {'given': 'M. A.', 'family': 'Davarpanah', 'sequence': 'first', 'affiliation': []}, {'given': 'R.', 'family': 'Adatorwovor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Y.', 'family': 'Mansoori', 'sequence': 'additional', 'affiliation': []}, {'given': 'F. S. R.', 'family': 'Ramsheh', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'Parsa', 'sequence': 'additional', 'affiliation': []}, {'given': 'M.', 'family': 'Hajiani', 'sequence': 'additional', 'affiliation': []}, {'given': 'H.', 'family': 'Faramarzi', 'sequence': 'additional', 'affiliation': []}, {'given': 'R.', 'family': 'Kavuluru', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4484-1971', 'authenticated-orcid': False, 'given': 'K.', 'family': 'Asadipooya', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2023, 6, 24]]}, 'reference': [ { 'key': '2141_CR1', 'unstructured': 'Hopkins J (2020) Coronavirus resource center. Im Internet (Stand: 1904 ' '2020). https://coronavirus.jhu.edu/map.html'}, { 'issue': '2', 'key': '2141_CR2', 'doi-asserted-by': 'publisher', 'first-page': '428', 'DOI': '10.1111/all.14657', 'volume': '76', 'author': 'YD Gao', 'year': '2021', 'unstructured': 'Gao YD, Ding M, Dong X, Zhang JJ, KursatAzkur A, Azkur D, Gan H, Sun YL, ' 'Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de ' 'Veen W, Sokolowska M, Akdis M, Akdis CA (2021) Risk factors for severe ' 'and critically ill COVID-19 patients: a review. Allergy 76(2):428–455', 'journal-title': 'Allergy'}, { 'issue': '23', 'key': '2141_CR3', 'doi-asserted-by': 'publisher', 'first-page': '858', 'DOI': '10.15585/mmwr.mm7023e2', 'volume': '70', 'author': 'A Christie', 'year': '2021', 'unstructured': 'Christie A, Henley SJ, Mattocks L, Fernando R, Lansky A, Ahmad FB, ' 'Adjemian J, Anderson RN, Binder AM, Carey K, Dee DL, Dias T, Duck WM, ' 'Gaughan DM, Lyons BC, McNaghten AD, Park MM, Reses H, Rodgers L, Van ' 'Santen K, Walker D, Beach MJ (2021) Decreases in COVID-19 cases, ' 'emergency department visits, hospital admissions, and deaths among older ' 'adults following the introduction of COVID-19 vaccine—United States, ' 'September 6, 2020-May 1, 2021. MMWR Morb Mortal Wkly Rep 70(23):858–864', 'journal-title': 'MMWR Morb Mortal Wkly Rep'}, { 'issue': '1', 'key': '2141_CR4', 'first-page': '236', 'volume': '20', 'author': 'T Kustin', 'year': '2021', 'unstructured': 'Kustin T, Harel N, Finkel U, Perchik S, Harari S, Tahor M, Caspi I, Levy ' 'R, Leshchinsky M, Ken Dror S, Bergerzon G, Gadban H, Gadban F, Eliassian ' 'E, Shimron O, Saleh L, Ben-Zvi H, Keren Taraday E, Amichay D, Ben-Dor A, ' 'Sagas D, Strauss M, Shemer Avni Y, Huppert A, Kepten E, Balicer RD, ' 'Netzer D, Ben-Shachar S, Stern A (2021) Evidence for increased ' 'breakthrough rates of SARS-CoV-2 variants of concern in ' 'BNT162b2-mRNA-vaccinated individuals. Nat Med 20(1):236', 'journal-title': 'Nat Med'}, { 'issue': '8', 'key': '2141_CR5', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/ofid/ofab376', 'volume': '8', 'author': 'J Xie', 'year': '2021', 'unstructured': 'Xie J, Wang Z, Liang J, Lin H, Yang Z, Wang Y, Liang H, Wu H, Chen R, Ou ' 'Y, Wang F, Wang Y, Wang Y, Luo W, Zhang J, Li N, Li Z, Jiang M, Li S, Li ' 'J (2021) Critical review of the scientific evidence and recommendations ' 'in COVID-19 management guidelines. Open Forum Infect Dis 8(8):ofab376', 'journal-title': 'Open Forum Infect Dis'}, { 'key': '2141_CR6', 'doi-asserted-by': 'crossref', 'unstructured': 'Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, ' 'Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo ' 'DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, ' 'Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, ' 'Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, ' 'Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos ' 'GD (2021) REGEN-COV antibody combination and outcomes in outpatients ' 'with Covid-19. New Eng J Med', 'DOI': '10.1056/NEJMoa2108163'}, { 'issue': '7', 'key': '2141_CR7', 'doi-asserted-by': 'publisher', 'first-page': '409', 'DOI': '10.1038/s41579-021-00573-0', 'volume': '19', 'author': 'WT Harvey', 'year': '2021', 'unstructured': 'Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, ' 'Ludden C, Reeve R, Rambaut A, Peacock SJ, Robertson DL (2021) SARS-CoV-2 ' 'variants, spike mutations and immune escape. Nat Rev Microbiol ' '19(7):409–424', 'journal-title': 'Nat Rev Microbiol'}, { 'issue': '4', 'key': '2141_CR8', 'doi-asserted-by': 'publisher', 'first-page': '717', 'DOI': '10.1038/s41591-021-01294-w', 'volume': '27', 'author': 'RE Chen', 'year': '2021', 'unstructured': 'Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, Liu J, ' 'Errico JM, Xie X, Suryadevara N, Gilchuk P, Zost SJ, Tahan S, Droit L, ' 'Turner JS, Kim W, Schmitz AJ, Thapa M, Wang D, Boon ACM, Presti RM, ' 'O’Halloran JA, Kim AHJ, Deepak P, Pinto D, Fremont DH, Crowe JE Jr, ' 'Corti D, Virgin HW, Ellebedy AH, Shi PY, Diamond MS (2021) Resistance of ' 'SARS-CoV-2 variants to neutralization by monoclonal and serum-derived ' 'polyclonal antibodies. Nat Med 27(4):717–726', 'journal-title': 'Nat Med'}, { 'key': '2141_CR9', 'doi-asserted-by': 'crossref', 'unstructured': 'Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) ' 'Structure, function, and antigenicity of the SARS-CoV-2 spike ' 'glycoprotein. Cell', 'DOI': '10.1101/2020.02.19.956581'}, { 'issue': '1', 'key': '2141_CR10', 'doi-asserted-by': 'publisher', 'first-page': '601', 'DOI': '10.1080/22221751.2020.1739565', 'volume': '9', 'author': 'N Vankadari', 'year': '2020', 'unstructured': 'Vankadari N, Wilce JA (2020) Emerging WuHan (COVID-19) coronavirus: ' 'glycan shield and structure prediction of spike glycoprotein and its ' 'interaction with human CD26. Emerg Microbes Infect 9(1):601–604', 'journal-title': 'Emerg Microbes Infect'}, { 'issue': '6483', 'key': '2141_CR11', 'doi-asserted-by': 'publisher', 'first-page': '1260', 'DOI': '10.1126/science.abb2507', 'volume': '367', 'author': 'D Wrapp', 'year': '2020', 'unstructured': 'Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham ' 'BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the ' 'prefusion conformation. Science (New York, NY) 367(6483):1260–1263', 'journal-title': 'Science (New York, NY)'}, { 'key': '2141_CR12', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fimmu.2020.576745', 'volume': '11', 'author': 'D Zipeto', 'year': '2020', 'unstructured': 'Zipeto D, Palmeira JDF, Argañaraz GA, Argañaraz ER (2020) ' 'ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19. ' 'Front Immunol 11:576745', 'journal-title': 'Front Immunol'}, { 'issue': '8', 'key': '2141_CR13', 'doi-asserted-by': 'publisher', 'first-page': '2212', 'DOI': '10.1016/j.cell.2021.02.053', 'volume': '184', 'author': 'ML Yeung', 'year': '2021', 'unstructured': 'Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai JP, Zhou R, Chan KH, ' 'Zhao H, Zhu L, Siu KL, Fung SY, Yung S, Chan TM, To KK, Chan JF, Cai Z, ' 'Lau SKP, Chen Z, Jin DY, Woo PCY, Yuen KY (2021) Soluble ACE2-mediated ' 'cell entry of SARS-CoV-2 via interaction with proteins related to the ' 'renin-angiotensin system. Cell 184(8):2212-2228.e2212', 'journal-title': 'Cell'}, { 'issue': '3', 'key': '2141_CR14', 'doi-asserted-by': 'publisher', 'first-page': '323', 'DOI': '10.1097/FJC.0000000000000960', 'volume': '77', 'author': 'CS Wilcox', 'year': '2020', 'unstructured': 'Wilcox CS, Pitt B (2020) Is spironolactone the preferred ' 'renin-angiotensin-aldosterone inhibitor for protection against COVID-19? ' 'J Cardiovasc Pharmacol 77(3):323–331', 'journal-title': 'J Cardiovasc Pharmacol'}, { 'issue': '7', 'key': '2141_CR15', 'doi-asserted-by': 'publisher', 'first-page': '979', 'DOI': '10.1136/hrt.2005.071829', 'volume': '92', 'author': 'M Satoh', 'year': '2006', 'unstructured': 'Satoh M, Ishikawa Y, Minami Y, Akatsu T, Nakamura M (2006) Eplerenone ' 'inhibits tumour necrosis factor alpha shedding process by tumour ' 'necrosis factor alpha converting enzyme in monocytes from patients with ' 'congestive heart failure. Heart 92(7):979–980', 'journal-title': 'Heart'}, { 'issue': '4', 'key': '2141_CR16', 'doi-asserted-by': 'publisher', 'first-page': '755', 'DOI': '10.1007/s11255-019-02074-9', 'volume': '51', 'author': 'D Dong', 'year': '2019', 'unstructured': 'Dong D, Fan TT, Ji YS, Yu JY, Wu S, Zhang L (2019) Spironolactone ' 'alleviates diabetic nephropathy through promoting autophagy in ' 'podocytes. Int Urol Nephrol 51(4):755–764', 'journal-title': 'Int Urol Nephrol'}, { 'issue': '9', 'key': '2141_CR17', 'doi-asserted-by': 'publisher', 'first-page': '946', 'DOI': '10.1161/01.RES.0000187500.24964.7A', 'volume': '97', 'author': 'S Keidar', 'year': '2005', 'unstructured': 'Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek ' 'T, Karry R, Abassi Z (2005) Mineralocorticoid receptor blocker increases ' 'angiotensin-converting enzyme 2 activity in congestive heart failure ' 'patients. Circ Res 97(9):946–953', 'journal-title': 'Circ Res'}, { 'issue': '3', 'key': '2141_CR18', 'doi-asserted-by': 'publisher', 'first-page': '777', 'DOI': '10.1016/j.dsx.2021.03.027', 'volume': '15', 'author': 'II Rakhmat', 'year': '2021', 'unstructured': 'Rakhmat II, Kusmala YY, Handayani DR, Juliastuti H, Nawangsih EN, Wibowo ' 'A, Lim MA, Pranata R (2021) Dipeptidyl peptidase-4 (DPP-4) inhibitor and ' 'mortality in coronavirus disease 2019 (COVID-19)—a systematic review, ' 'meta-analysis, and meta-regression. Diabet Metab Syndrome 15(3):777–782', 'journal-title': 'Diabet Metab Syndrome'}, { 'issue': '4', 'key': '2141_CR19', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/jendso/bvac017', 'volume': '6', 'author': 'F Abbasi', 'year': '2022', 'unstructured': 'Abbasi F, Adatorwovor R, Davarpanah MA, Mansoori Y, Hajiani M, Azodi F, ' 'Sefidbakht S, Davoudi S, Rezaei F, Mohammadmoradi S, Asadipooya K (2022) ' 'A randomized trial of sitagliptin and spironolactone with combination ' 'therapy in hospitalized adults with COVID-19. J Endocr Soc 6(4):bvac017', 'journal-title': 'J Endocr Soc'}, { 'key': '2141_CR20', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.genrep.2021.101341', 'volume': '25', 'author': 'F Rahimi', 'year': '2021', 'unstructured': 'Rahimi F, TalebiBezmin Abadi A (2021) Emergence of the delta plus ' 'variant of SARS-CoV-2 in Iran. Gene Reports 25:101341', 'journal-title': 'Gene Reports'}, { 'issue': '9', 'key': '2141_CR21', 'doi-asserted-by': 'publisher', 'first-page': '1476', 'DOI': '10.1093/jamia/ocaa141', 'volume': '27', 'author': 'M Garcia', 'year': '2020', 'unstructured': 'Garcia M, Lipskiy N, Tyson J, Watkins R, Esser ES, Kinley T (2020) ' 'Centers for Disease Control and Prevention 2019 novel coronavirus ' 'disease (COVID-19) information management: addressing national ' 'health-care and public health needs for standardized data definitions ' 'and codified vocabulary for data exchange. J Am Med Inform Assoc ' '27(9):1476–1487', 'journal-title': 'J Am Med Inform Assoc'}, { 'issue': '24', 'key': '2141_CR22', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/MD.0000000000026371', 'volume': '100', 'author': 'JE Blair', 'year': '2021', 'unstructured': 'Blair JE, Gotimukul A, Wang F, Mina SA, Bartels HC, Burns MW, Kole AE, ' 'Vikram HR, Gea-Banacloche JC, Seville MT, Petty SAB, Vikram A, Orenstein ' 'R (2021) Mild to moderate COVID-19 illness in adult outpatients: ' 'characteristics, symptoms, and outcomes in the first 4 weeks of illness. ' 'Medicine 100(24):e26371', 'journal-title': 'Medicine'}, { 'key': '2141_CR23', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fpubh.2020.551889', 'volume': '8', 'author': 'R Rahmanzade', 'year': '2020', 'unstructured': 'Rahmanzade R, Rahmanzadeh R, Hashemian SM, Tabarsi P (2020) Iran’s ' 'approach to COVID-19: evolving treatment protocols and ongoing clinical ' 'trials. Front Public Health 8:551889', 'journal-title': 'Front Public Health'}, { 'issue': '1', 'key': '2141_CR24', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0245840', 'volume': '16', 'author': 'S Goodacre', 'year': '2021', 'unstructured': 'Goodacre S, Thomas B, Sutton L, Burnsall M, Lee E, Bradburn M, Loban A, ' 'Waterhouse S, Simmonds R, Biggs K, Marincowitz C, Schutter J, Connelly ' 'S, Sheldon E, Hall J, Young E, Bentley A, Challen K, Fitzsimmons C, ' 'Harris T, Lecky F, Lee A, Maconochie I, Walter D (2021) Derivation and ' 'validation of a clinical severity score for acutely ill adults with ' 'suspected COVID-19: the PRIEST observational cohort study. PLoS\xa0One ' '16(1):e0245840', 'journal-title': 'PLoS\xa0One'}, { 'issue': '7', 'key': '2141_CR25', 'doi-asserted-by': 'publisher', 'first-page': '877', 'DOI': '10.1080/14787210.2021.1863146', 'volume': '19', 'author': 'HF Tsang', 'year': '2021', 'unstructured': 'Tsang HF, Chan LWC, Cho WCS, Yu ACS, Yim AKY, Chan AKC, Ng LPW, Wong ' 'YKE, Pei XM, Li MJW, Wong SC (2021) An update on COVID-19 pandemic: the ' 'epidemiology, pathogenesis, prevention and treatment strategies. Expert ' 'Rev Anti Infect Ther 19(7):877–888', 'journal-title': 'Expert Rev Anti Infect Ther'}, { 'issue': '9', 'key': '2141_CR26', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmjopen-2021-049505', 'volume': '11', 'author': 'EF Peacocke', 'year': '2021', 'unstructured': 'Peacocke EF, Heupink LF, Frønsdal K, Dahl EH, Chola L (2021) Global ' 'access to COVID-19 vaccines: a scoping review of factors that may ' 'influence equitable access for low and middle-income countries. BMJ Open ' '11(9):e049505', 'journal-title': 'BMJ Open'}, { 'issue': '1', 'key': '2141_CR27', 'doi-asserted-by': 'publisher', 'first-page': '16', 'DOI': '10.1016/j.amjmed.2020.07.003', 'volume': '134', 'author': 'PA McCullough', 'year': '2021', 'unstructured': 'McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, Katz ' 'N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, ' 'Palazzuoli A, De Ferrari GM, Milligan GP, Safder T, Tecson KM, Wang DD, ' 'McKinnon JE, O’Neill WW, Zervos M, Risch HA (2021) Pathophysiological ' 'basis and rationale for early outpatient treatment of SARS-CoV-2 ' '(COVID-19) infection. Am J Med 134(1):16–22', 'journal-title': 'Am J Med'}, { 'key': '2141_CR28', 'first-page': '763', 'volume': '9', 'author': 'TC Lee', 'year': '2022', 'unstructured': 'Lee TC, Bortolussi-Courval É, Belga S, Daneman N, Chan AK, Hanula R, ' 'Ezer N, McDonald EG (2022) Inhaled corticosteroids for outpatients with ' 'Covid-19: a meta-analysis. Eur Respir J 9:763', 'journal-title': 'Eur Respir J'}, { 'issue': '6', 'key': '2141_CR29', 'doi-asserted-by': 'publisher', 'first-page': '509', 'DOI': '10.1056/NEJMoa2116044', 'volume': '386', 'author': 'A Jayk Bernal', 'year': '2022', 'unstructured': 'Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, ' 'Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, Du ' 'J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, ' 'Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C (2022) ' 'Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. ' 'New Eng J Med 386(6):509–520', 'journal-title': 'New Eng J Med'}, { 'issue': '15', 'key': '2141_CR30', 'doi-asserted-by': 'publisher', 'first-page': '1397', 'DOI': '10.1056/NEJMoa2118542', 'volume': '386', 'author': 'J Hammond', 'year': '2022', 'unstructured': 'Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, ' 'Baniecki M, Hendrick VM, Damle B, Simón-Campos A, Pypstra R, Rusnak JM ' '(2022) Oral Nirmatrelvir for high-risk, nonhospitalized adults with ' 'Covid-19. N Engl J Med 386(15):1397–1408', 'journal-title': 'N Engl J Med'}, { 'issue': '4', 'key': '2141_CR31', 'doi-asserted-by': 'publisher', 'first-page': '305', 'DOI': '10.1056/NEJMoa2116846', 'volume': '386', 'author': 'RL Gottlieb', 'year': '2022', 'unstructured': 'Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, ' 'Ryan P, Nielsen BU, Brown M, Hidalgo A, Sachdeva Y, Mittal S, Osiyemi O, ' 'Skarbinski J, Juneja K, Hyland RH, Osinusi A, Chen S, Camus G, ' 'Abdelghany M, Davies S, Behenna-Renton N, Duff F, Marty FM, Katz MJ, ' 'Ginde AA, Brown SM, Schiffer JT, Hill JA (2022) Early remdesivir to ' 'prevent progression to severe Covid-19 in outpatients. N Engl J Med ' '386(4):305–315', 'journal-title': 'N Engl J Med'}, { 'key': '2141_CR32', 'volume-title': 'Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of ' 'serious illness, company reports', 'author': 'E Mahase', 'year': '2021', 'unstructured': 'Mahase E (2021) Covid-19: Pfizer’s paxlovid is 89% effective in patients ' 'at risk of serious illness, company reports. British Medical Journal ' 'Publishing Group'}, { 'issue': '5', 'key': '2141_CR33', 'doi-asserted-by': 'publisher', 'first-page': '2222', 'DOI': '10.1002/jmv.27623', 'volume': '94', 'author': 'WT Lin', 'year': '2022', 'unstructured': 'Lin WT, Hung SH, Lai CC, Wang CY, Chen CH (2022) The impact of ' 'neutralizing monoclonal antibodies on the outcomes of COVID-19 ' 'outpatients: a systematic review and meta-analysis of randomized ' 'controlled trials. J Med Virol 94(5):2222–2229', 'journal-title': 'J Med Virol'}, { 'key': '2141_CR34', 'doi-asserted-by': 'crossref', 'unstructured': 'Coulson JM, Adams A, Gray LA, Evans A (2022) COVID-19 "Rebound" ' 'associated with nirmatrelvir/ritonavir pre-hospital therapy. J Infect ' '85(4):436–480', 'DOI': '10.1016/j.jinf.2022.06.011'}, { 'issue': '5', 'key': '2141_CR35', 'doi-asserted-by': 'publisher', 'first-page': '2367', 'DOI': '10.1007/s11845-021-02820-y', 'volume': '191', 'author': 'A Vitiello', 'year': '2022', 'unstructured': 'Vitiello A (2022) Sars-Cov-2 and risk of antiviral drug resistance. Ir J ' 'Med Sci 191(5):2367–2368', 'journal-title': 'Ir J Med Sci'}, { 'key': '2141_CR36', 'first-page': '57', 'volume': '3', 'author': 'A Komorowski', 'year': '2022', 'unstructured': 'Komorowski A, Tseng A, Vandersluis S (2022) Evidence-based ' 'recommendations on the use of nirmatrelvir/ritonavir (Paxlovid) for ' 'adults in Ontario. Sci Brief Ontario COVID-19 Sci Advisory Table 3:57', 'journal-title': 'Sci Brief Ontario COVID-19 Sci Advisory Table'}, { 'issue': '10327', 'key': '2141_CR37', 'doi-asserted-by': 'publisher', 'first-page': '779', 'DOI': '10.1016/S0140-6736(22)00372-5', 'volume': '399', 'author': 'AD Usher', 'year': '2022', 'unstructured': 'Usher AD (2022) The global COVID-19 treatment divide. Lancet (London, ' 'England) 399(10327):779–782', 'journal-title': 'Lancet (London, England)'}, { 'issue': '1', 'key': '2141_CR38', 'doi-asserted-by': 'publisher', 'first-page': '165', 'DOI': '10.1093/cid/ciac180', 'volume': '76', 'author': 'LD Saravolatz', 'year': '2023', 'unstructured': 'Saravolatz LD, Depcinski S, Sharma M (2023) Molnupiravir and ' 'nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs. ' 'Clin Infect Dis 76(1):165–171', 'journal-title': 'Clin Infect Dis'}, { 'issue': '4', 'key': '2141_CR39', 'doi-asserted-by': 'publisher', 'first-page': '905', 'DOI': '10.1016/j.cell.2020.04.004', 'volume': '181', 'author': 'V Monteil', 'year': '2020', 'unstructured': 'Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, Stahl M, Leopoldi ' 'A, Garreta E, Hurtado Del Pozo C, Prosper F, Romero JP, Wirnsberger G, ' 'Zhang H, Slutsky AS, Conder R, Montserrat N, Mirazimi A, Penninger JM ' '(2020) Inhibition of SARS-CoV-2 infections in engineered human tissues ' 'using clinical-grade soluble human ACE2. Cell 181(4):905-913.e907', 'journal-title': 'Cell'}, { 'issue': '4', 'key': '2141_CR40', 'doi-asserted-by': 'publisher', 'first-page': '795', 'DOI': '10.1681/ASN.2020101537', 'volume': '32', 'author': 'J Wysocki', 'year': '2021', 'unstructured': 'Wysocki J, Ye M, Hassler L, Gupta AK, Wang Y, Nicoleascu V, Randall G, ' 'Wertheim JA, Batlle D (2021) A novel soluble ACE2 variant with prolonged ' 'duration of action neutralizes SARS-CoV-2 infection in human kidney ' 'organoids. J Am Soc Nephrol 32(4):795–803', 'journal-title': 'J Am Soc Nephrol'}, { 'issue': '1', 'key': '2141_CR41', 'doi-asserted-by': 'publisher', 'first-page': '182', 'DOI': '10.1186/s12931-020-01445-6', 'volume': '21', 'author': 'J Xu', 'year': '2020', 'unstructured': 'Xu J, Xu X, Jiang L, Dua K, Hansbro PM, Liu G (2020) SARS-CoV-2 induces ' 'transcriptional signatures in human lung epithelial cells that promote ' 'lung fibrosis. Respir Res 21(1):182', 'journal-title': 'Respir Res'}, { 'key': '2141_CR42', 'doi-asserted-by': 'crossref', 'unstructured': 'Angeli F, Zappa M, Reboldi G, Trapasso M, Cavallini C, Spanevello A, ' 'Verdecchia P (2021) The pivotal link between ACE2 deficiency and ' 'SARS-CoV-2 infection: one year later. Eur J Intern Med 93:28–34', 'DOI': '10.1016/j.ejim.2021.09.007'}, { 'key': '2141_CR43', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmed.2021.629176', 'volume': '8', 'author': 'D Jeon', 'year': '2021', 'unstructured': 'Jeon D, Son M, Choi J (2021) Effect of spironolactone on COVID-19 in ' 'patients with underlying liver cirrhosis: a nationwide case-control ' 'study in South Korea. Front Med 8:629176', 'journal-title': 'Front Med'}, { 'issue': '11', 'key': '2141_CR44', 'doi-asserted-by': 'publisher', 'first-page': '4', 'DOI': '10.18087/cardio.2020.11.n1440', 'volume': '60', 'author': 'VY Mareev', 'year': '2020', 'unstructured': 'Mareev VY, Orlova YA, Plisyk AG, Pavlikova EP, Matskeplishvili ST, ' 'Akopyan ZA, Seredenina EM, Potapenko AV, Agapov MA, Asratyan DA, Dyachuk ' 'LI, Samokhodskaya LM, Mershina E, Sinitsyn VE, Pakhomov PV, Bulanova MM, ' 'Fuks AA, Mareev YV, Begrambekova YL, Kamalov A (2020) results of ' 'open-label non-randomized comparative clinical trial: “bromhexine and ' 'spironolactone for coronavirus infection requiring hospitalization” ' '(BISCUIT). Kardiologiia 60(11):4–15', 'journal-title': 'Kardiologiia'}, { 'issue': '1', 'key': '2141_CR45', 'doi-asserted-by': 'publisher', 'first-page': '3', 'DOI': '10.1038/s41580-021-00418-x', 'volume': '23', 'author': 'CB Jackson', 'year': '2022', 'unstructured': 'Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 ' 'entry into cells. Nat Rev Mol Cell Biol 23(1):3–20', 'journal-title': 'Nat Rev Mol Cell Biol'}, { 'key': '2141_CR46', 'doi-asserted-by': 'crossref', 'unstructured': 'Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K (2021) Severe ' 'Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a systemic ' 'infection. Clin Microbiol Rev 34(2):e00133–e00120', 'DOI': '10.1128/CMR.00133-20'}, { 'issue': '7', 'key': '2141_CR47', 'doi-asserted-by': 'publisher', 'first-page': '779', 'DOI': '10.1007/s00592-020-01539-z', 'volume': '57', 'author': 'SB Solerte', 'year': '2020', 'unstructured': 'Solerte SB, Di Sabatino A, Galli M, Fiorina P (2020) Dipeptidyl ' 'peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol 57(7):779–783', 'journal-title': 'Acta Diabetol'}, { 'key': '2141_CR48', 'doi-asserted-by': 'crossref', 'unstructured': 'Bakhtiari M, Asadipooya K (2022) Metainflammation in COVID-19. Endocr ' 'Metab Immune Disord Drug Targets 22(12):1154–1166', 'DOI': '10.2174/1871530322666220104103325'}, { 'issue': '7', 'key': '2141_CR49', 'doi-asserted-by': 'publisher', 'first-page': '1579', 'DOI': '10.2337/db21-0926', 'volume': '71', 'author': 'M Ben Nasr', 'year': '2022', 'unstructured': 'Ben Nasr M, D’Addio F, Montefusco L, Usuelli V, Loretelli C, Rossi A, ' 'Pastore I, Abdelsalam A, Maestroni A, Dell’Acqua M, Ippolito E, Assi E, ' 'Seelam AJ, Fiorina RM, Chebat E, Morpurgo P, Lunati ME, Bolla AM, Abdi ' 'R, Bonventre JV, Rusconi S, Riva A, Corradi D, Santus P, Clark P, ' 'Nebuloni M, Baldi G, Finzi G, Folli F, Zuccotti GV, Galli M, Herold KC, ' 'Fiorina P (2022) Indirect and direct effects of SARS-CoV-2 on human ' 'pancreatic islets. Diabetes 71(7):1579–1590', 'journal-title': 'Diabetes'}, { 'issue': '2', 'key': '2141_CR50', 'doi-asserted-by': 'publisher', 'first-page': '149', 'DOI': '10.1038/s42255-021-00347-1', 'volume': '3', 'author': 'JA Müller', 'year': '2021', 'unstructured': 'Müller JA, Groß R, Conzelmann C, Krüger J, Merle U, Steinhart J, Weil T, ' 'Koepke L, Bozzo CP, Read C, Fois G, Eiseler T, Gehrmann J, van Vuuren J, ' 'Wessbecher IM, Frick M, Costa IG, Breunig M, Grüner B, Peters L, ' 'Schuster M, Liebau S, Seufferlein T, Stenger S, Stenzinger A, MacDonald ' 'PE, Kirchhoff F, Sparrer KMJ, Walther P, Lickert H, Barth TFE, Wagner M, ' 'Münch J, Heller S, Kleger A (2021) SARS-CoV-2 infects and replicates in ' 'cells of the human endocrine and exocrine pancreas. Nat Metab ' '3(2):149–165', 'journal-title': 'Nat Metab'}, { 'issue': '6', 'key': '2141_CR51', 'doi-asserted-by': 'publisher', 'first-page': '774', 'DOI': '10.1038/s42255-021-00407-6', 'volume': '3', 'author': 'L Montefusco', 'year': '2021', 'unstructured': 'Montefusco L, Ben Nasr M, D’Addio F, Loretelli C, Rossi A, Pastore I, ' 'Daniele G, Abdelsalam A, Maestroni A, Dell’Acqua M, Ippolito E, Assi E, ' 'Usuelli V, Seelam AJ, Fiorina RM, Chebat E, Morpurgo P, Lunati ME, Bolla ' 'AM, Finzi G, Abdi R, Bonventre JV, Rusconi S, Riva A, Corradi D, Santus ' 'P, Nebuloni M, Folli F, Zuccotti GV, Galli M, Fiorina P (2021) Acute and ' 'long-term disruption of glycometabolic control after SARS-CoV-2 ' 'infection. Nat Metab 3(6):774–785', 'journal-title': 'Nat Metab'}, { 'key': '2141_CR52', 'doi-asserted-by': 'crossref', 'unstructured': "Loretelli C, Abdelsalam A, D'Addio F, Ben Nasr M, Assi E, Usuelli V, " 'Maestroni A, Seelam AJ, Ippolito E, Di Maggio S, Loreggian L, ' 'Radovanovic D, Vanetti C, Yang J, El Essawy B, Rossi A, Pastore I, ' 'Montefusco L, Lunati ME, Bolla AM, Biasin M, Antinori S, Santus P, Riva ' 'A, Zuccotti GV, Galli M, Rusconi S, Fiorina P (2021) PD-1 blockade ' 'counteracts post-COVID-19 immune abnormalities and stimulates the ' 'anti-SARS-CoV-2 immune response. JCI Insight 6(24):e146701', 'DOI': '10.1172/jci.insight.146701'}, { 'key': '2141_CR53', 'doi-asserted-by': 'crossref', 'unstructured': 'Asadipooya K (2022) Letter to the editor from Asadipooya: “obesity and ' 'COVID-19: mechanistic insights from adipose tissue”. J Clin Endocrinol ' 'Metab 107(10):e4269', 'DOI': '10.1210/clinem/dgac450'}, { 'key': '2141_CR54', 'doi-asserted-by': 'crossref', 'unstructured': 'Davarpanah MA, Adatorwovor R, Mansoori Y, Ramsheh FSR, Parsa A, Hajiani ' 'M, Faramarzi H, Kavuluru R, Asadipooya K (2022) Combination of ' 'spironolactone and sitagliptin improves clinical outcomes of outpatients ' 'with COVID-19: a prospective cohort study. medRxiv. ' '2022.2001.2021.22269322', 'DOI': '10.22541/au.165403085.53671439/v1'}, { 'issue': '11', 'key': '2141_CR55', 'doi-asserted-by': 'publisher', 'first-page': '642', 'DOI': '10.1038/s41574-020-0399-8', 'volume': '16', 'author': 'CF Deacon', 'year': '2020', 'unstructured': 'Deacon CF (2020) Dipeptidyl peptidase 4 inhibitors in the treatment of ' 'type 2 diabetes mellitus. Nat Rev Endocrinol 16(11):642–653', 'journal-title': 'Nat Rev Endocrinol'}, { 'key': '2141_CR56', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.metabol.2020.154295', 'volume': '109', 'author': 'AP Stoian', 'year': '2020', 'unstructured': 'Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA (2020) ' 'The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to ' 'other oral glucose-lowering medications in the treatment of type 2 ' 'diabetes. Metabolism 109:154295', 'journal-title': 'Metabolism'}, { 'issue': '4', 'key': '2141_CR57', 'doi-asserted-by': 'publisher', 'first-page': '1233', 'DOI': '10.1210/jc.2018-00241', 'volume': '103', 'author': 'KA Martin', 'year': '2018', 'unstructured': 'Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat ' 'MM, Rosenfield RL (2018) Evaluation and treatment of hirsutism in ' 'premenopausal women: an endocrine society clinical practice guideline. J ' 'Clin Endocrinol Metab 103(4):1233–1257', 'journal-title': 'J Clin Endocrinol Metab'}], 'container-title': 'Journal of Endocrinological Investigation', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40618-023-02141-0.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s40618-023-02141-0/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40618-023-02141-0.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 1, 9]], 'date-time': '2024-01-09T19:14:07Z', 'timestamp': 1704827647000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s40618-023-02141-0'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 6, 24]]}, 'references-count': 57, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2024, 1]]}}, 'alternative-id': ['2141'], 'URL': 'http://dx.doi.org/10.1007/s40618-023-02141-0', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.1101/2022.01.21.22269322', 'asserted-by': 'object'}]}, 'ISSN': ['1720-8386'], 'subject': [], 'container-title-short': 'J Endocrinol Invest', 'published': {'date-parts': [[2023, 6, 24]]}, 'assertion': [ { 'value': '6 February 2023', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '16 June 2023', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '24 June 2023', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The authors have declared that no conflict of interest exists.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of interest'}}, { 'value': 'IRCT registration number: IRCT20201003048904N2, Registration date: December 10, ' '2020.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Iranian registry of clinical trial'}}]}